CARDIOTOXICITY MONITORING WITH A NOVEL COMBINED APPROACH OF TELEMEDICINE AND BIOMARKERS IN LYMPHOMA PATIENTS TREATED WITH CONVENTIONAL AND LIPOSOMAL ANTHRACYCLINES
G. Guido,J. Olivieri,B. Caterina,M. Dottori,S. Trappolini,C. Montevecchi,G. Perna,P. Leoni,A. Olivieri
